1-9 of 9
Swe Mar Linn
Close
Sort by
Journal Articles

Propensity Score Matching Comparing Asciminib Versus Ponatinib in Chronic Myeloid Leukemia Patients Who Failed Prior Tyrosine Kinase Inhibitor Therapy

Maria Agustina Perusini, Camille Kockerols, Daniela Žáčková, Franck E. Nicolini, Fausto Castagnetti, Carolina Pavlovsky, Massimo Breccia, Delphine Rea, Carmen Fava, Mary Lynn Savoie, Christophe Bouvier, Petra Čičátková, Julien Bollard, Swe Mar Linn, Gopila Gupta, Emilia Scalzulli, Jiří Mayer, Peter E Westerweel, Dennis Dong Hwan Kim
Journal: Blood
Blood (2023) 142 (Supplement 1): 6360.
https://doi.org/10.1182/blood-2023-190293
Published: 2023
Journal Articles

Retrospective, Multi-Center Analysis of Ruxolitinib Tapering after Successful Treatment of Steroid Refractory Chronic Graft Versus Host Disease

Daniel Levin, Kareem Jamani, Swe Mar Linn, Benoit Yu, Arjun D. Law, Rajat Kumar, Christopher Lemieux, Mohamed Elemary, Dennis Dong Hwan Kim
Journal: Blood
Blood (2023) 142 (Supplement 1): 4934.
https://doi.org/10.1182/blood-2023-188204
Published: 2023
Journal Articles

Real-World Experience with Ruxolitinib Therapy for Steroid Refractory Acute Graft Versus Host Disease

Alistair Murray, Swe Mar Linn, Benoit Yu, Igor Novitzky-Basso, Jonas Mattsson, Mohamed Elemary, Jennifer White, Christopher Lemieux, Kareem Jamani, Dennis Kim
Journal: Blood
Blood (2022) 140 (Supplement 1): 7662–7663.
https://doi.org/10.1182/blood-2022-164874
Published: 2022
Journal Articles

Propensity Score Matching Analysis Comparing Extracorporeal Photopheresis (ECP) Vs Best Available Therapy in Third Line or Later Treatment of Chronic Graft-Versus-Host Disease (cGVHD)

Swe Mar Linn, Igor Novitzky-Basso, Elizabeth Shin, Christopher J. Patriquin, Ivan Pasic, Wilson Lam, Arjun Law, Fotios Michelis, Armin Gerbitz, Auro Viswabandya, Jeffrey H. Lipton, Rajat Kumar, Jonas Mattsson, David Barth, Dennis Dong Hwan Kim, Sr.
Journal: Blood
Blood (2021) 138 (Supplement 1): 3896.
https://doi.org/10.1182/blood-2021-153045
Published: 2021
Journal Articles

Update of Multicenter, Retrospective Evaluation of Overall Response and Failure Free Survival Following Ruxolitinib Therapy for Heavily Pre-Treated Chronic Gvhd Patients with Steroid-Failure: A Proposal of Risk Score Model for Failure-Free Survival

Jennifer White, Mohamed Elemary, Swe Mar Linn, Igor Novitzky-Basso, Anargyros Xenocostas, Nada Hamad, Samantha Culos, Sui Tan, Arjun Law, Rajat Kumar, Jonas Mattsson, Dennis Dong Hwan Kim, Sr.
Journal: Blood
Blood (2021) 138 (Supplement 1): 3905.
https://doi.org/10.1182/blood-2021-148859
Published: 2021
Journal Articles

Propensity Score Matching Analysis Comparing Ruxolitinib Vs Historical Controls in 2 nd Line or Beyond Treatment for Chronic Gvhd after Therapy Failure

Igor Novitzky-Basso, Swe Mar Linn, Jennifer White, Mohamed Elemary, Anargyros Xenocostas, Nada Hamad, Sui Tan, Samantha Culos, Arjun Law, Dennis Dong Hwan Kim
Journal: Blood
Blood (2021) 138 (Supplement 1): 1805.
https://doi.org/10.1182/blood-2021-151683
Published: 2021
Journal Articles

Single Centre, Retrospective Analysis of Extracorporeal Photopheresis (ECP) Therapy in the Patients Who Are Heavily Pre-Treated for Steroid Resistant Chronic Graft-Versus-Host Disease (GVHD)

Swe Mar Linn, Igor Novitzky-Basso, Christopher J. Patriquin, Ivan Pasic, Wilson Lam, Arjun Law, Fotios Michelis, Armin Gerbitz, Auro Viswabandya, Jeffrey H. Lipton, Rajat Kumar, Jonas Mattsson, David Barth, Dennis Dong Hwan Kim, Sr.
Journal: Blood
Blood (2021) 138 (Supplement 1): 1806.
https://doi.org/10.1182/blood-2021-152640
Published: 2021
Journal Articles

Single Centre, Retrospective Study to Evaluate Treatment Outcomes Following Tyrosine Kinase Inhibitor for Chronic Gvhd Treatment Including Ruxolitinib, Ibrutinib and Imatinib

Swe Mar Linn, MBBS, Omar Abduljalil, Igor Nicolas Novitzky-Basso, MDPhDMRCP,FRCPath, RAM V Nampoothiri, MDDM MRCP (UK), Ivan Pasic, MDPhD, Zeyad Al-Shaibani, MD, Wilson Lam, MD, Arjun Law, MD, Fotios Michelis, MD PhD, Armin Gerbitz, MDPhD, Auro Viswabandya, MD, Jeffrey H. Lipton, MD PhD, Rajat Kumar, MD, Jonas Mattson, MD PhD, Dennis Dong Hwan Kim, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 17–18.
https://doi.org/10.1182/blood-2020-142182
Published: 2020
Journal Articles

Multicenter, Retrospective Evaluation of Therapeutic Efficacy of Ruxolitinib for Chronic Gvhd Treatment

Jennifer White, Nada Hamad, MBBS,BSc,MSc,FRACP FRCPA, Swe Mar Linn, MBBS, Igor Nicolas Novitzky-Basso, MDPhDMRCP,FRCPath, Omar Abduljalil, Arjun Law, MD, Dennis Dong Hwan Kim, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 45–47.
https://doi.org/10.1182/blood-2020-136164
Published: 2020